Advertisement

Table of Contents

July 01, 1995; Volume 48,Issue 1

You have access
Regulation of adenylyl cyclase type VI activity during desensitization of the A2a adenosine receptor-mediated cyclic AMP response: role for protein phosphatase 2A.
Y Chern, J Y Chiou, H L Lai and M H Tsai

Molecular Pharmacology July 1995, 48 (1) 1-8;
You have access
Studies on neuropeptide Y receptors in a mouse adrenocortical cell line.
G Weng, F Yee, P Michl, D Reis and C Wahlestedt

Molecular Pharmacology July 1995, 48 (1) 9-14;
You have access
Inhibition of human immunodeficiency virus type 1 replication by 7-methyl-6,8-bis(methylthio)pyrrolo[1,2-a]pyrazine, an in vivo metabolite of oltipraz.
H J Prochaska, W G Bornmann, P Baron and B Polsky

Molecular Pharmacology July 1995, 48 (1) 15-20;
You have access
B9209-005, an azido derivative of the chemosensitizer dexniguldipine-HCl, photolabels P-glycoprotein.
C Borchers, W R Ulrich, K Klemm, W Ise, V Gekeler, S Haas, A Schödl, J Conrad, M Przybylski and R Boer

Molecular Pharmacology July 1995, 48 (1) 21-29;
You have access
Topoisomerase II DNA cleavage stimulation, DNA binding activity, cytotoxicity, and physico-chemical properties of 2-aza- and 2-aza-oxide-anthracenedione derivatives.
P De Isabella, M Palumbo, C Sissi, G Capranico, N Carenini, E Menta, A Oliva, S Spinelli, A P Krapcho and F C Giuliani

Molecular Pharmacology July 1995, 48 (1) 30-38;
You have access
Role of protein kinase C subtypes alpha and delta in the regulation of bradykinin-stimulated phosphoinositide breakdown in astrocytes.
C C Chen, J Chang and W C Chen

Molecular Pharmacology July 1995, 48 (1) 39-47;
You have access
Targeted inactivation of the gene encoding the mouse alpha 2c-adrenoceptor homolog.
R E Link, M S Stevens, M Kulatunga, M Scheinin, G S Barsh and B K Kobilka

Molecular Pharmacology July 1995, 48 (1) 48-55;
You have access
Differentiation induces pituitary adenylate cyclase-activating polypeptide receptor expression in PC-12 cells.
S Cavallaro, V D'Agata, V Guardabasso, S Travali, F Stivala and P L Canonico

Molecular Pharmacology July 1995, 48 (1) 56-62;
You have access
Pituitary adenylate cyclase-activating polypeptide type I receptors mediate cyclic AMP-dependent enhancement of neuronal acetylcholine sensitivity.
J F Margiotta and D Pardi

Molecular Pharmacology July 1995, 48 (1) 63-71;
You have access
Biphasic binding of 5-fluoro-2'-deoxyuridylate to human thymidylate synthase.
R T Reilly, K W Barbour, R B Dunlap and F G Berger

Molecular Pharmacology July 1995, 48 (1) 72-79;
You have access
Relationship of the metabolism of vitamins C and E in cultured hepatocytes treated with tert-butyl hydroperoxide.
P A Glascott, E Gilfor and J L Farber

Molecular Pharmacology July 1995, 48 (1) 80-88;
You have access
Voltage- and frequency-dependent pentobarbital suppression of brain and muscle sodium channels expressed in a mammalian cell line.
B Rehberg, E Bennett, Y H Xiao, S R Levinson and D S Duch

Molecular Pharmacology July 1995, 48 (1) 89-97;
You have access
WIN 17317-3: novel nonpeptide antagonist of voltage-activated K+ channels in human T lymphocytes.
R J Hill, A M Grant, W Volberg, L Rapp, C Faltynek, D Miller, K Pagani, E Baizman, S Wang and J W Guiles

Molecular Pharmacology July 1995, 48 (1) 98-104;
You have access
alpha-Conotoxins selectively inhibit one of the two acetylcholine binding sites of nicotinic receptors.
D R Groebe, J M Dumm, E S Levitan and S N Abramson

Molecular Pharmacology July 1995, 48 (1) 105-111;
You have access
Phenytoin-initiated DNA oxidation in murine embryo culture, and embryo protection by the antioxidative enzymes superoxide dismutase and catalase: evidence for reactive oxygen species-mediated DNA oxidation in the molecular mechanism of phenytoin teratogenicity.
L M Winn and P G Wells

Molecular Pharmacology July 1995, 48 (1) 112-120;
You have access
Erythro-9-(2-hydroxy-3-nonyl)adenine inhibits cyclic GMP-stimulated phosphodiesterase in isolated cardiac myocytes.
P F Méry, C Pavoine, F Pecker and R Fischmeister

Molecular Pharmacology July 1995, 48 (1) 121-130;
You have access
Omega-grammotoxin SIA blocks multiple, voltage-gated, Ca2+ channel subtypes in cultured rat hippocampal neurons.
T M Piser, R A Lampe, R A Keith and S A Thayer

Molecular Pharmacology July 1995, 48 (1) 131-139;
You have access
Type 4a metabotropic glutamate receptor: identification of new potent agonists and differentiation from the L-(+)-2-amino-4-phosphonobutanoic acid-sensitive receptor in the lateral perforant pathway in rats.
P A Johansen, L A Chase, A D Sinor, J F Koerner, R L Johnson and M B Robinson

Molecular Pharmacology July 1995, 48 (1) 140-149;
You have access
Serotonergic antagonists differentially inhibit spontaneous activity and decrease ligand binding capacity of the rat 5-hydroxytryptamine type 2C receptor in Sf9 cells.
J Labrecque, A Fargin, M Bouvier, P Chidiac and M Dennis

Molecular Pharmacology July 1995, 48 (1) 150-159;
You have access
Effects of n-dodecylguanidine on A-type potassium channels: role of external surface charges in channel gating.
J A Yao, N C Saxena, M R Ziai, S Ling and G N Tseng

Molecular Pharmacology July 1995, 48 (1) 160-171;